Altium Capital Management LLC
NEW YORK, NY · CIK 1746382 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAltium Capital Management LLC (US)
- Others nearbyNew York, NY
$236.5m
reported value
-17.6% vs Q1 2022
120positions
29.0%in top 10
26 new
16 added
13 reduced
23 sold out
vs Q1 2022
Options: 4 call positions ($7.7m notional), 2 put positions ($5.8m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CHINOOK THERAPEUTICS INC ADRO | $10.8m4.55% | Added +70.0k |
| BELLUS HEALTH INC NEW BLU | $8.4m3.56% | Reduced -538.0k |
| ADMA BIOLOGICS INC ADMA | $7.9m3.35% | Added +700.0k |
| ESPERION THERAPEUTICS INC NE ESPR | $7.4m3.13% | Reduced -1.3m |
| PEPPERLIME HEALTH ACQUSTN CO CLASS A ORD SHS | $7.3m3.07% | New |
| LANTHEUS HLDGS INC LNTH | $5.8m2.46% | Added +48.0k |
| STAAR SURGICAL CO STAA | $5.3m2.25% | New |
| INSMED INC INSM | $5.3m2.24% | Unchanged |
| GLAUKOS CORP GKOS | $5.2m2.19% | Added +20.0k |
| CYMABAY THERAPEUTICS INC CBAY | $5.2m2.18% | Unchanged |
| NOCTURNE ACQUISITION CORP ORDINARY SHARES | $5.1m2.15% | Unchanged |
| QUIDELORTHO CORP QDEL | $4.9m2.05% | New |
| INSPIRE MED SYS INC INSP | $4.4m1.85% | Added +8.0k |
| INTRA-CELLULAR THERAPIES INC ITCI | $4.3m1.81% | Added +52.5k |
| GUARDANT HEALTH INC GH | $4.2m1.79% | New |
| MYRIAD GENETICS INC MYGN | $4.0m1.70% | Added +106.3k |
| CHEMOCENTRYX INC CCXI | $4.0m1.68% | New |
| EUCRATES BIOMEDICAL ACQU COR SHS | $4.0m1.67% | Unchanged |
| NEVRO CORP NVRO | $3.9m1.65% | Added +12.0k |
| AKOYA BIOSCIENCES INC AKYA | $3.8m1.61% | New |
| INOGEN INC INGN | $3.8m1.60% | New |
| TREVI THERAPEUTICS INC TRVI | $3.6m1.53% | New |
| VERASTEM INC COM | $3.5m1.47% | Added +49.0k |
| DEXCOM INC DXCM | $3.3m1.39% | Reduced -6.0k |
| XTANT MED HLDGS INC XTNT | $3.2m1.37% | Unchanged |
| CARA THERAPEUTICS INC COM | $3.2m1.36% | Added +188.2k |
| PROCEPT BIOROBOTICS CORP PRCT | $3.2m1.36% | Added +50.9k |
| KARYOPHARM THERAPEUTICS INC COM | $3.2m1.34% | Added +55.0k |
| LIVANOVA PLC LIVN | $3.1m1.32% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $2.8m1.18% | Unchanged |
| EIGER BIOPHARMACEUTICALS INC CLDN | $2.8m1.17% | Unchanged |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $2.7m1.15% | Added +31.0k |
| KURA ONCOLOGY INC KURA | $2.7m1.14% | New |
| 908 DEVICES INC MASS | $2.6m1.09% | New |
| KORU MEDICAL SYSTEMS INC KRMD | $2.5m1.07% | Unchanged |
| TURMERIC ACQUISITION CORP CL A | $2.5m1.06% | Unchanged |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $2.4m1.03% | New |
| KEROS THERAPEUTICS INC KROS | $2.4m1.03% | Reduced -38.0k |
| SHOCKWAVE MED INC SWAV | $2.3m0.97% | Reduced -11.0k |
| IVERIC BIO INC OPHT | $2.3m0.96% | Unchanged |
| SARISSA CAPITAL ACQUISITN CO CL A | $2.2m0.94% | Unchanged |
| ADICET BIO INC COM | $2.2m0.93% | Reduced -5.0k |
| AVIDITY BIOSCIENCES INC RNA | $2.2m0.92% | Reduced -93.0k |
| GOSSAMER BIO INC GOSS | $2.2m0.92% | New |
| NEUROCRINE BIOSCIENCES INC NBIX | $2.1m0.91% | New |
| COLLEGIUM PHARMACEUTICAL INC COLL | $2.1m0.87% | New |
| GIGINTERNATIONAL1 INC COM | $2.0m0.85% | Unchanged |
| TG VENTURE ACQUISITION CORP UNIT 08/15/2028 | $2.0m0.85% | Unchanged |
| LAKESHORE ACQUISITION I CORP ORDINARY SHARES | $2.0m0.84% | Unchanged |
| CHAVANT CAPITAL ACQUISITN CO ORDINARY SHARES | $2.0m0.84% | Unchanged |
| JIYA ACQUISITION CORP COM CL A | $2.0m0.84% | Unchanged |
| HILLMAN SOLUTIONS CORP HLMN | $1.9m0.81% | Added +25.0k |
| ILLUMINA INC ILMN | $1.8m0.78% | Reduced -1.0k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $1.8m0.75% | Unchanged |
| KARUNA THERAPEUTICS INC COM | $1.6m0.70% | Reduced -8.0k |
| AGIOS PHARMACEUTICALS INC AGIO | $1.6m0.68% | Added +6.8k |
| 1847 GOEDEKER INC *W EXP 06/02/202 | $1.6m0.67% | Unchanged |
| OUTSET MED INC OM | $1.5m0.65% | Added +51.9k |
| DIGITAL HEALTH ACQUISITION C UNIT 11/02/2026 | $1.5m0.64% | Unchanged |
| AULT DISRUPTIVE TECHS CORP COM | $1.5m0.64% | Unchanged |
| REZOLUTE INC RZLT | $1.3m0.56% | New |
| MORPHIC HLDG INC MORF | $1.3m0.55% | Unchanged |
| TAILWIND ACQUISITION CORP COM CL A | $1.3m0.54% | Unchanged |
| IMMUNOGEN INC IMGN | $1.3m0.53% | Reduced -640.0k |
| ALTIMMUNE INC ALT | $1.2m0.49% | Reduced -223.3k |
| PROMETHEUS BIOSCIENCES INC COM | $1.1m0.47% | New |
| 2SEVENTY BIO INC TSVT | $1.1m0.46% | Reduced -32.0k |
| RELATIVITY ACQUISITION CORP UNIT 02/10/2027 | $1.0m0.43% | Unchanged |
| MURPHY CANYON ACQUISITION CO UNIT 01/25/2027 | $1.0m0.43% | Unchanged |
| INDUSTRIAL HUMAN CAPITAL INC COM | $1.0m0.42% | Unchanged |
| WESTERN ACQSTN VENTURES CORP UNIT 09/01/2026 | $1.0m0.42% | Unchanged |
| BCLS ACQUISITION CORP COM CL A | $990.0k0.42% | Unchanged |
| OMEGA ALPHA SPAC CL A | $985.0k0.42% | Unchanged |
| OPY ACQUISITION CORP I COM CL A | $984.0k0.42% | Unchanged |
| ARYA SCIENCES ACQU CORP IV CL A | $981.0k0.41% | Unchanged |
| FAT BRANDS INC FATBW | $965.0k0.41% | Unchanged |
| HOLLEY INC HLLY | $840.0k0.36% | New |
| COLISEUM ACQUISITION CORP CLASS A ORD SHS | $827.0k0.35% | Unchanged |
| PEPGEN INC PEPG | $794.0k0.34% | New |
| RENOVACOR INC COM | $788.0k0.33% | Unchanged |
| ANGIODYNAMICS INC ANGO | $767.0k0.32% | New |
| MUSCLE MAKER INC COM | $692.0k0.29% | Unchanged |
| LIANBIO LIANY | $681.0k0.29% | New |
| STOKE THERAPEUTICS INC STOK | $634.0k0.27% | New |
| DOUBLEDOWN INTERACTIVE CO LT DDI | $588.0k0.25% | Unchanged |
| GERON CORP GERN | $576.0k0.24% | New |
| ALKERMES PLC ALKS | $536.0k0.23% | New |
| RELMADA THERAPEUTICS INC RLMD | $532.0k0.22% | Reduced -178.0k |
| GSR II METEORA ACQUISITN COR UNIT 02/24/2027 | $499.0k0.21% | Unchanged |
| COLOMBIER ACQUISITION CORP CL A | $488.0k0.21% | Unchanged |
| SAGE THERAPEUTICS INC SAGE | $485.0k0.21% | New |
| SURGEPAYS INC *W EXP 10/22/202 | $300.0k0.13% | Unchanged |
| LIGHTNING EMOTORS INC *W EXP 05/18/202 | $255.0k0.11% | Unchanged |
| HARBOR CUSTOM DEVELOPMENT IN *W EXP 10/04/202 | $244.0k0.10% | Unchanged |
| TC BIOPHARM HOLDINGS PLC TCBWF | $223.0k0.09% | Unchanged |
| IMMATICS N.V IMTXW | $199.0k0.08% | Unchanged |
| DIGITAL BRANDS GROUP INC COM | $195.0k0.08% | New |
| HARBOR CUSTOM DEVELOPMENT IN *W EXP 05/09/202 | $116.0k0.05% | Unchanged |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $100.0k0.04% | Unchanged |
| CINGULATE INC CINGW | $85.0k0.04% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| PROTAGONIST THERAPEUTICS INC PTGX | $9.1m386.0k shares |
| PEPPERLIME HEALTH ACQUSTN CO | $7.2m735.0k shares |
| QUIDEL CORP QDEL | $6.3m56.0k shares |
| GLOBUS MED INC GMED | $5.8m79.0k shares |
| TANDEM DIABETES CARE INC TNDM | $5.8m50.0k shares |
| BICYCLE THERAPEUTICS PLC BCYC | $5.3m120.0k shares |
| ENVISTA HOLDINGS CORPORATION NVST | $5.1m105.0k shares |
| QIAGEN NV | $4.6m93.0k shares |
| CRINETICS PHARMACEUTICALS IN CRNX | $4.5m204.0k shares |
| IMMUNIC INC | $3.4m300.0k shares |
| CELLDEX THERAPEUTICS INC NEW CLDX | $2.2m66.0k shares |
| SILENCE THERAPEUTICS PLC SLN | $2.1m109.0k shares |
| PARDES BIOSCIENCES INC | $1.8m253.0k shares |
| CYTOMX THERAPEUTICS INC CTMX | $1.8m663.8k shares |
| SOMALOGIC INC SLGC | $1.4m180.0k shares |
| CTI BIOPHARMA CORP | $1.4m299.8k shares |
| CURIS INC | $1.3m540.8k shares |
| PROFOUND MED CORP PROF | $1.1m124.9k shares |
| CUTERA INC CUTR | $1.0m15.0k shares |
| ACHIEVE LIFE SCIENCES INC ACHV | $924.0k122.0k shares |
| VIQ SOLUTIONS INC VQSSF | $798.0k489.4k shares |
| VERRICA PHARMACEUTICALS INC | $794.0k97.9k shares |
| CALITHERA BIOSCIENCES INC CALA | $82.0k202.3k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| GUARDANT HEALTH INC GH · Call | $4.0m100.0k shares | New |
| AMYLYX PHARMACEUTICALS INC AMLX · Put | $3.9m200.0k shares | New |
| PROTAGONIST THERAPEUTICS INC PTGX · Call | $2.9m365.1k shares | Added |
| AXSOME THERAPEUTICS INC AXSM · Put | $1.9m50.0k shares | New |
| ATHIRA PHARMA INC Call | $610.0k200.1k shares | New |
| BRIDGEBIO PHARMA INC BBIO · Call | $158.0k17.4k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| GREENLANE HLDGS INC 13G · filed 2025-02-28 | 10.0% |
| SHARPS TECHNOLOGY INC 13G · filed 2025-02-05 | 10.0% |
| FEMTO TECHNOLOGIES INC 13G · filed 2025-03-06 | 9.6% |